Boston Scientific Debt to Equity Ratio 2006-2018 | BSX

Current and historical debt to equity ratio values for Boston Scientific (BSX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Boston Scientific debt/equity for the three months ending December 31, 2018 was 0.55.
Boston Scientific Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-12-31 $4.80B $8.73B 0.55
2018-09-30 $4.81B $8.29B 0.58
2018-06-30 $4.81B $7.74B 0.62
2018-03-31 $4.80B $7.03B 0.68
2017-12-31 $3.82B $7.01B 0.54
2017-09-30 $4.42B $7.59B 0.58
2017-06-30 $4.82B $7.24B 0.67
2017-03-31 $5.51B $7.05B 0.78
2016-12-31 $5.42B $6.73B 0.81
2016-09-30 $5.17B $6.48B 0.80
2016-06-30 $5.17B $6.22B 0.83
2016-03-31 $5.42B $6.46B 0.84
2015-12-31 $5.67B $6.32B 0.90
2015-09-30 $5.80B $6.41B 0.90
2015-06-30 $5.07B $6.58B 0.77
2015-03-31 $3.85B $6.50B 0.59
2014-12-31 $3.84B $6.46B 0.60
2014-09-30 $4.25B $6.70B 0.63
2014-06-30 $4.25B $6.54B 0.65
2014-03-31 $4.25B $6.53B 0.65
2013-12-31 $4.24B $6.54B 0.65
2013-09-30 $4.25B $6.56B 0.65
2013-06-30 $3.65B $6.60B 0.55
2013-03-31 $4.25B $6.50B 0.65
2012-12-31 $4.25B $6.87B 0.62
2012-09-30 $4.25B $6.83B 0.62
2012-06-30 $4.25B $7.73B 0.55
2012-03-31 $4.26B $11.40B 0.37
2011-12-31 $4.26B $11.35B 0.38
2011-09-30 $4.26B $11.52B 0.37
2011-06-30 $4.20B $11.54B 0.36
2011-03-31 $4.67B $11.37B 0.41
2010-12-31 $4.93B $11.30B 0.44
2010-09-30 $5.13B $11.04B 0.47
2010-06-30 $5.18B $10.89B 0.48
2010-03-31 $5.67B $10.78B 0.53
2009-12-31 $5.92B $12.30B 0.48
2009-09-30 $5.77B $13.30B 0.43
2009-06-30 $5.92B $13.41B 0.44
2009-03-31 $6.24B $13.28B 0.47
2008-12-31 $6.74B $13.17B 0.51
2008-09-30 $6.77B $15.69B 0.43
2008-06-30 $7.01B $15.64B 0.45
2008-03-31 $7.31B $15.39B 0.48
2007-12-31 $7.93B $15.10B 0.53
2007-09-30 $7.90B $15.52B 0.51
2007-06-30 $8.25B $15.80B 0.52
2007-03-31 $8.90B $15.55B 0.57
2006-12-31 $8.90B $15.30B 0.58
2006-09-30 $8.89B $15.02B 0.59
2006-06-30 $8.89B $14.89B 0.60
2006-03-31 $1.84B $4.67B 0.39
2005-12-31 $1.86B $4.28B 0.44
2005-09-30 $2.43B $3.90B 0.62
2005-06-30 $1.52B $4.22B 0.36
2005-03-31 $1.12B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $51.696B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29